Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

GALT RSS Feed
Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator XenaLives, 123tom
Search This Board:
Last Post: 10/28/2014 4:13:32 PM - Followers: 38 - Board type: Free - Posts Today: 0

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.
 

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:

 

Fibrosis

 

Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.

 

Cancer

 

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GALT
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for GALT
GALT News: Statement of Changes in Beneficial Ownership (4) 09/24/2014 04:36:09 PM
GALT News: Initial Statement of Beneficial Ownership (3) 09/24/2014 04:34:23 PM
GALT News: Current Report Filing (8-k) 09/24/2014 07:46:54 AM
GALT News: Current Report Filing (8-k) 09/15/2014 07:45:16 AM
GALT News: Current Report Filing (8-k) 09/12/2014 03:00:19 PM
PostSubject
#1534  Sticky Note This is my final post on any public biotech2010 09/24/14 04:59:33 PM
#1586   Were you being sarcastic? We're up almost 6%... thefamilyman 10/28/14 04:13:32 PM
#1585   wow what a day, retail gets screwed over oldsport 10/28/14 04:01:41 PM
#1584   updating my summary from 3 weeks ago.... 123tom 10/26/14 06:36:46 PM
#1583   Just putting this out here. GR-MD-02 is a Darwinian 10/25/14 04:28:51 PM
#1582   Nice & quiet board. Enjoy the sub 2$ warrants. Adi2 10/25/14 08:10:49 AM
#1581   eventually sideliners are gonna pour in, november comin.... oldsport 10/24/14 09:59:19 AM
#1580   another 1/4 mil $ share ask up plus oldsport 10/23/14 01:38:39 PM
#1579   some1 took the mm s huge ask by oldsport 10/23/14 01:26:09 PM
#1578   same person again, over 1/2 mil $ worth oldsport 10/23/14 12:43:57 PM
#1577   no it could be had, up forever... oldsport 10/22/14 10:33:52 PM
#1576   If that's a real offer size. It's not like davidc2 10/22/14 09:41:12 PM
#1575   may be true but over half mil $ oldsport 10/22/14 06:31:11 PM
#1574   very low volume day. shorts walking it jmh0602 10/22/14 05:46:16 PM
#1573   wow some1 is desperate to get out oldsport 10/22/14 02:52:07 PM
#1572   ebola runnin dry... was hoping it flowed back oldsport 10/20/14 12:23:10 PM
#1571   Tom, not a big Elliot Wave guy but davidc2 10/19/14 09:39:24 PM
#1570   I would reread those to no end thinking davidc2 10/14/14 08:01:51 PM
#1568   this is a lotto play for sure... loosing oldsport 10/12/14 01:25:45 AM
#1566   "No offense" but I am certain that what thefamilyman 10/11/14 05:39:53 PM
#1563   Not allowed? No offense but you gotta be davidc2 10/10/14 03:54:40 PM
#1562   I resemble that remark! :-). And the thefamilyman 10/09/14 11:01:10 PM
#1561   I stand corrected, it was ISCO. The IRAHopeful 10/09/14 05:49:37 PM
#1560   When Patrick was with Agora, he was not thefamilyman 10/09/14 04:21:24 PM
#1559   In all my following of Pat Cox, he IRAHopeful 10/09/14 04:11:27 PM
#1558   John Mauldin was on the BOD long before DirectionalDriller 10/09/14 03:16:08 PM
#1557   idk? what would promoter look like ? oldsport 10/09/14 12:53:17 PM
#1556   AF has it that one of the stock davidc2 10/09/14 11:45:58 AM
#1555   GALT chart....at 4.60....and bottom zone 123tom 10/07/14 12:52:44 PM
#1554   retail headed over to ebola companies, great loading oldsport 10/05/14 04:29:51 PM
#1553   Interim results for Cohort3 are expected along with DirectionalDriller 10/02/14 04:51:10 PM
#1551   Where did you get the Nov. 9th date? IRAHopeful 10/02/14 02:27:14 PM
#1550   Nov 9, not October jmh0602 10/01/14 07:17:02 PM
#1549   Oct 9 update on phase 1 cohorts, including #3. jmh0602 10/01/14 07:05:13 PM
#1548   my GALT forecast from last week updated.... 123tom 10/01/14 06:36:29 PM
#1547   Thanks Biotech 2010....I value your commentary on 123tom 09/26/14 08:06:54 PM
#1546   could be time to take the galt plunge daMonsta 09/26/14 03:33:36 PM
#1545   Icpt 5.2 billion Cap. GALT 115. Opportunity. Adi2 09/26/14 01:06:20 PM
#1544   Quote: Me " Does galectin3 drop the shied" spelled DirectionalDriller 09/26/14 01:47:37 AM
#1543   I got out and back in still green, DirectionalDriller 09/26/14 12:16:32 AM
#1542   Every party has to have one. It's IRAHopeful 09/25/14 03:18:11 PM
#1540   thefamilyman: I noticed the same thing from Tesla1 09/25/14 12:48:01 PM
#1539   Party pooper... ;-) thefamilyman 09/24/14 07:05:14 PM
#1538   glta, come back when we do well... oldsport 09/24/14 06:44:48 PM
#1537   At the recent investor conference, Traber said he IRAHopeful 09/24/14 06:27:11 PM
#1536   Sorry to see you go. You will thefamilyman 09/24/14 05:07:23 PM
#1535   Originally, the data for the third Cohort was thefamilyman 09/24/14 05:04:19 PM
#1534   This is my final post on any public biotech2010 09/24/14 04:59:33 PM
#1533   Ok, ...well we got the bounce today.... BUT 123tom 09/24/14 02:28:43 PM
#1532   well the train has reached a central station 123tom 09/23/14 04:27:46 PM
#1531   yea the stock market sucks, u have to bcareful oldsport 09/20/14 05:04:45 PM
PostSubject